Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine

Vaccine

Volumn 29, Issue 1, 2010, Pages 1-5

  McConnell, Michael J ^a   Pachón, Jerónimo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Acinetobacter baumannii; Passive immunization; Vaccine

Indexed keywords

INACTIVATED VACCINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEPSIS; WESTERN BLOTTING; WHOLE CELL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE SERA; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED C57BL; SEPSIS; VACCINATION; VACCINES, INACTIVATED;

EID: 78649690656     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.052     Document Type: Article

References (18)

1. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N Engl J Med 2008, 358(March (12)):1271-1281.
2. Jones A., Morgan D., Walsh A., Turton J., Livermore D., Pitt T., et al. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq. Lancet Infect Dis 2006, 6(June (6)):317-318.
3. Ho P.L., Cheng V.C., Chu C.M. Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii. Chest 2009, 136(October (4)):1119-1127.
4. Sengstock D.M., Thyagarajan R., Apalara J., Mira A., Chopra T., Kaye K.S. Multidrug-Resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 2010, 50(June (12)):1617-1618.
5. Vila J., Pachon J. Therapeutic options for Acinetobacter baumannii infections. Expert Opin Pharmacother 2008, 9(March (4)):587-599.
6. Adams M.D., Nickel G.C., Bajaksouzian S., Lavender H., Murthy A.R., Jacobs M.R., et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother 2009, 53(September (9)):3628-3634.
7. Taccone F.S., Rodriguez-Villalobos H., De Backer D., De Moor V., Deviere J., Vincent J.L., et al. Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline. Eur J Clin Microbiol Infect Dis 2006, 25(April (4)):257-260.
8. Valencia R., Arroyo L.A., Conde M., Aldana J.M., Torres M.J., Fernandez-Cuenca F., et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol 2009, 30(March (3)):257-263.
9. Billips B.K., Yaggie R.E., Cashy J.P., Schaeffer A.J., Klumpp D.J. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis 2009, 200(July (2)):263-272.
10. Cripps A.W., Dunkley M.L., Clancy R.L. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infect Immun 1994, 62(April (4)):1427-1436.
11. Cripps A.W., Peek K., Dunkley M., Vento K., Marjason J.K., McIntyre M.E., et al. Safety and immunogenicity of an oral inactivated whole-cell Pseudomonas aeruginosa vaccine administered to healthy human subjects. Infect Immun 2006, 74(February (2)):968-974.
12. Zaidi T.S., Priebe G.P., Pier G.B. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Infect Immun 2006, 74(February (2)):975-983.
13. Fernandez-Cuenca F., Pascual A., Ribera A., Vila J., Bou G., Cisneros J.M., et al. Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project 2000. Enferm Infecc Microbiol Clin 2004, 22(May (5)):267-271.
14. Cuenca F.F., Pascual A., Martinez Marinez L., Conejo M.C., Perea E.J. Evaluation of SDS-polyacrylamide gel systems for the study of outer membrane protein profiles of clinical strains of Acinetobacter baumannii. J Basic Microbiol 2003, 43(3):194-201.
15. McConnell M.J., Hanna P.C., Imperiale M.J. Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4. Infect Immun 2006, 74(February (2)):1009-1015.
16. Martin R.M., Brady J.L., Lew A.M. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods 1998, 212(March (2)):187-192.
17. Vila J., Marti S., Sanchez-Cespedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007, 59(June (6)):1210-1215.
18. Schaffer A.C., Lee J.C. Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents 2008, 32(November (Suppl. 1)):S71-S78.